BRAF inhibitor shows promising preclinical activity against melanoma
Tuesday, June 15, 2010 - 13:21
in Health & Medicine
Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032) inhibited proliferation of tumor cell lines that expressed V600E-BRAF, a mutation found in several human cancers, including melanoma.